Exendin-3

• Description:

  Exendin-3 is a biologically active peptides isolated from venoms of the Gila monster lizards, Heloderma horridurn.

• UNSPSC:

  12352209

• Target:

  Amylases; GCGR; GLP Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein; Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/Exendin-3.html

• Purity:

  98.31

• Solubility:

  H2O

• Smiles:

  O=C (N[C@@H] (CO) C (N[C@@H] (CC (O) =O) C (NCC (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CC1=CC=CC=C1) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CO) C (N[C@@H] (CC (O) =O) C (N[C@@H] (CC (C) C) C (N[C@@H] (CO) C (N[C@@H] (CCCCN) C (N[C@@H] (CCC (N) =O) C (N[C@@H] (CCSC) C (N[C@@H] (CCC (O) =O) C (N[C@@H] (CCC (O) =O) C (N[C@@H] (CCC (O) =O) C (N[C@@H] (C) C (N[C@@H] (C (C) C) C (N[C@@H] (CCCNC (N) =N) C (N[C@@H] (CC (C) C) C (N[C@@H] (CC2=CC=CC=C2) C (N[C@@H] ([C@@H] (C) CC) C (N[C@@H] (CCC (O) =O) C (N[C@@H] (CC3=CNC4=CC=CC=C34) C (N[C@@H] (CC (C) C) C (N[C@@H] (CCCCN) C (N[C@@H] (CC (N) =O) C (NCC (NCC (N5[C@@H] (CCC5) C (N[C@@H] (CO) C (N[C@@H] (CO) C (NCC (N[C@@H] (C) C (N6[C@@H] (CCC6) C (N7[C@@H] (CCC7) C (N8[C@@H] (CCC8) C (N[C@@H] (CO) C (N) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) [C@H] (CC9=CNC=N9) N

• Molecular Formula:

  C184H282N50O61S

• Molecular Weight:

  4202.57

• References & Citations:

  [1]Raufman JP, et al. Exendin-3, a novel peptide from Heloderma horridum venom, interacts with vasoactive intestinal peptide receptors and a newly described receptor on dispersed acini from guinea pig pancreas. Description of exendin-3 (9-39) amide, a specific exendin receptor antagonist. J Biol Chem. 1991 Feb 15;266 (5) :2897-902.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  130357-25-4